Blue Horseshoe Stocks: Options Success Continues

OPTIONS REVIEW

First thing’s first today, we’re going to highlight the total possible gains which have resulted from options ideas we’ve posted in our morning reports over the past three trading days.

On Friday morning, we slated the GlaxoSmithKline plc GSK 05/17 $41 Calls for observation, and have seen a very solid increase since then. The $41 Calls were trading as low as .32 the morning of our alert, and yesterday, reached a high of .65. That marks a three-day swing of 103% The company posted an earnings beat this morning, so we’ll continue to monitor for any further potential progress here.
_____

Yesterday morning, we flagged the Seagate Technology plc STX Weekly $46.50-47.50 Calls, and were met with instant good fortune with those ideas. The single-session gains on this set of ideas was excellent:

$46.50 Calls – Range: 1.02-2.25 – Max Gain: 121%
$47 Calls – Range: .75-1.65 – Max Gain: 120%
$47.50 Calls – Range: .75-1.35 – Max Gain: 80%
_____

Lastly, also in yesterday’s report, we had the GE Weekly $10 Calls, and those fared reasonably well also, trading in a daily range from .19-.35 (+84%).
_____

POST-EARNINGS OPTIONS IDEAS:
Apple, Inc. AAPL Weekly $207.50-210 Calls

CVS Corp. CVS Weekly $56-58 Calls


Extended Watchlist:
HEB, OCUL, MTOR, GRPN, SNGX, CRSP. IPHI

Blue Horseshoe Stocks: AMPG Update & More

OPTIONS RECAPAfter recapping the excellent success we had with Friday’s options ideas in yesterday’s morning report, we formulated an idea for the SPY to correspond to Friday’s extremely bullish close of the markets.

We had designated the SPY 04/29 $292.50-293.50 Calls to watch for yesterday, and we are happy to report that gains on this one-day idea were certainly available for anyone who caught our alert, and those were as follows:

$292.50 Calls – Range: 1.16-1.91 – Max Gain: 65%
$293 Calls – Range: .57-1.45 – Max Gain: 154%
$293.50 Calls – Range: .35-.95  – Max Gain: 171%
_____

FRESH OPTIONS IDEAS:
STX Weekly $46.50-47.50 Calls
GE Weekly $10 Calls


AmpliTech Group, Inc. AMPGWe also wanted to track back to AMPG, which we profiled at the beginning of last month (>>View Report). The company recently added an independent director, with a wealth of related experience, and we feel the company has made an excellent choice.
_______

On April 25, 2019, Wayne Homschek was appointed as a director of Amplitech Group, Inc Mr. Homschek is independent using the definition of independence under NASDAQ Listing Rule 5605(a)(2) and the standards established by the SEC. Therefore, the Company intends to appoint Mr. Homschek as chairman of the audit committee, compensation committee and nominating committee on the formation thereof.

Wayne Homschek has been a Managing Director at Bentley Associates L.P. (“Bentley”), a New York based boutique investment bank specializing in mergers and acquisitions and private financings, since 2015.  Mr Homschek currently sits on the Board of AR Orthopedic Holdings, LLC, a private-equity backed life sciences company. Prior to joining Bentley, Mr Homschek founded and grew a multinational hospitality company (from 2003 to 2014), growing the company to over $50mm in sales during his tenure.  Mr Homschek began his career in investment banking at the Prudential Investment Corporation in 1987 in New York, was transferred to Sydney, Australia in 1989, and moved to Salomon Smith Barney/Citigroup in 1998, where he ran the firm’s Australasian telecom, media and technology franchise until 2002. (>>View Full 8-K)

_____

Stay tuned for further coverage on AMPG, which is now trading significantly higher than where it was when we first came across it, and continuing to gear up for a fruitful 2019. 


Extended Watchlist:
VERB, HEB, HSGX, YUMC, PINS, ZYNE, VRNS, NXPI

Blue Horseshoe Stocks: DMPI Recap & More

Del Mar Pharmaceuticals, Inc . DMPI

We wanted to swing back around to recap the solid performance of DMPI since we tagged it the day after the Christmas break a couple of weeks back.

It was just a couple sessions later that the stock would find support at .96, and begin a pretty substantial run up the chart. It was helped along by the last six consecutive sessions registering higher base levels of support as the stock has crept all the way up to a high of 1.75, recorded on Friday.

That worked out to a move of 82% in less than two trading weeks, while volume over the same period has been heightened. The high coincided with the current 200DMA, so we’ll look for DMPI to possibly crack that 1.75 mark and head for blue skies.



Kohls Corp KSS

We want to include an options idea for Kohls as we kick off the first full trading week of 2018, on the heels of a solid earnings report.

The company posted strong sales for the holiday season, while giving a significant boost to full year guidance. Shares jumped accordingly in premarket trading, and we are going to be waiting with some targeted weekly contracts to coincide with the activity. We’re going to signal and track the KSS Weekly $58-60 Calls.


Extended Watchlist:
STX, UEPS, ARGS, SDRL, VRAY, NTEC, IMNP, KBSF